Prothena Corporation plc
PRTA
$9.60
$0.171.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1,706.36% | -99.01% | 148.97% | -96.65% | 5,556.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,706.36% | -99.01% | 148.97% | -96.65% | 5,556.00% |
| Cost of Revenue | -75.15% | -70.93% | -42.95% | -29.55% | -20.75% |
| Gross Profit | 180.15% | 69.69% | 46.69% | -148.45% | 25.10% |
| SG&A Expenses | -28.03% | -24.94% | -21.01% | -1.35% | 0.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -63.03% | -59.37% | -37.50% | -23.37% | -16.14% |
| Operating Income | 139.33% | 58.07% | 40.22% | -189.09% | 19.56% |
| Income Before Tax | 153.32% | 63.73% | 38.31% | -224.86% | 17.55% |
| Income Tax Expenses | 100.08% | 100.65% | 55.57% | 2,297.25% | 46.48% |
| Earnings from Continuing Operations | 154.36% | 62.75% | 38.07% | -288.03% | 16.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 154.36% | 62.75% | 38.07% | -288.03% | 16.67% |
| EBIT | 139.33% | 58.07% | 40.22% | -189.09% | 19.56% |
| EBITDA | 139.74% | 58.26% | 40.36% | -188.35% | 19.62% |
| EPS Basic | 154.48% | 62.75% | 38.12% | -287.82% | 16.85% |
| Normalized Basic EPS | 146.51% | 58.68% | 39.16% | -174.49% | 17.73% |
| EPS Diluted | 153.57% | 62.75% | 38.12% | -291.80% | 16.72% |
| Normalized Diluted EPS | 146.15% | 58.68% | 39.16% | -176.26% | 17.73% |
| Average Basic Shares Outstanding | -0.22% | 0.03% | 0.07% | 0.11% | 0.21% |
| Average Diluted Shares Outstanding | 0.52% | 0.03% | 0.07% | -2.21% | 0.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |